Filed in the “This is why we can’t have nice things” category, U.S. Attorney General Jeff Sessions is once again using his power to make life as hard as possible for medicinal cannabis users. And this time, a century-old D.C. think tank is not letting it go.
On October 26, Sessions answered questions from a Senate Judiciary Committee on government-approved medicinal cannabis research. Specifically, Senator Orrin Hatch questioned Sessions on the hold-up around the approval of 26 applications from private groups to grow weed, for research and clinical trial usage. Sessions’ response? “I think it would be healthy to have some more competition in the supply, but I don’t—I’m sure we don’t need 26 new suppliers.” For some context, Washington state alone has more than one hundred known weed farms.
In August 2016, the DEA announced that it would mellow out a little bit and begin to take applications from groups who